Filtros de búsqueda

Lista de obras de

A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

artículo científico publicado en 2018

Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study

scientific article published on 17 October 2019

Daratumumab for relapsed AL amyloidosis - when cumulative real-world data precedes clinical trials: A multisite study and systematic literature review

scientific article published on 14 October 2020

Daratumumab resistance is frequent in advanced stage multiple myeloma patients irrespectively of CD38 expression, and is related to dismal prognosis.

artículo científico publicado en 2018

Gastrointestinal perforation in light chain amyloidosis in the era of novel agent therapy - a case series and review of the literature.

artículo científico publicado en 2017

Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group

artículo científico publicado en 2020

Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma

scientific article published on 03 April 2019

The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

artículo científico publicado en 2020

The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis.

artículo científico publicado en 2018

Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda